Cargando…
Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity
SIMPLE SUMMARY: The phosphoinositide-3-kinase (PI3K) pathway is the most frequently activated pathway in human cancers. Consequently, a number of compounds targeting the various nodes of this pathway have been developed. However, the majority of these compounds have been unsuccessful in patients due...
Autores principales: | Wright, Sarah Christine Elisabeth, Vasilevski, Natali, Serra, Violeta, Rodon, Jordi, Eichhorn, Pieter Johan Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037590/ https://www.ncbi.nlm.nih.gov/pubmed/33810522 http://dx.doi.org/10.3390/cancers13071538 |
Ejemplares similares
-
OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex
por: Jaynes, Patrick William, et al.
Publicado: (2020) -
Ubiquitination and adaptive responses to BRAF inhibitors in Melanoma
por: Saei, Azad, et al.
Publicado: (2018) -
Adaptive Responses as Mechanisms of Resistance to BRAF Inhibitors in Melanoma
por: Saei, Azad, et al.
Publicado: (2019) -
Proposal to study the coherent 3 $\pi$ , 5 $\pi$ and K $\pi \pi$ production on nuclei at the Serpukhov accelerator
por: Tyapkin, A A, et al.
Publicado: (1973) -
Enhanced antiviral immunity and dampened inflammation in llama lymph nodes upon MERS-CoV sensing: bridging innate and adaptive cellular immune responses in camelid reservoirs
por: Rodon, Jordi, et al.
Publicado: (2023)